Victory Capital Management Inc Singular Genomics Systems, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$2.5 - $4.73 $285,745 - $540,629	-114,298 Reduced 65.31%	60,723 $152,000
Q2 2022 Aug 01, 2022	BUY	$2.86 - $6.44 $763 - $1,719	267 Added 0.15%	175,021 $669,000
Q1 2022 May 04, 2022	SELL	$5.94 - $12.09 $28,250 - $57,500	-4,756 Reduced 2.65%	174,754 $966,000
Q4 2021 Feb 07, 2022	SELL	$10.45 - $16.9 $217,610 - $351,925	-20,824 Reduced 10.39%	179,510 $2.08 Million
Q3 2021 Nov 02, 2021	BUY	$10.9 - $27.63 $34,792 - $88,194	3,192 Added 1.62%	200,334 $2.24 Million
Q2 2021 Aug 03, 2021	BUY	$23.16 - $31.17 $4.57 Million - $6.14 Million	197,142 New	197,142 $5.42 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.42B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.